Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Bell JL, Wächter K, Mühleck B, Pazaitis N, Köhn M, Lederer M, Hüttelmaier S. · 2013
Read Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? by Bell JL, Wächter K, Mühleck B, Pazaitis N, Köhn M, Lederer M, Hüttelmaier S. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3708292.txt.
Introduction
Bell and colleagues review the IGF2BP family of RNA-binding proteins. These three related proteins steer what cells do with their messages. The review covers their growing links to cancer. The proteins are mainly active before birth. There they shape cell movement, growth, and differentiation. They are quiet in most adult tissues.
Two family members switch back on in several aggressive cancers, where they support the traits that make tumours dangerous. The review connects these cancer roles to the proteins' normal developmental jobs. It argues they may drive tumour growth rather than merely mark it. It also weighs them as drug targets and biomarkers worth testing.
Catalog record
| CREATOR | Bell JL, Wächter K, Mühleck B, Pazaitis N, Köhn M, Lederer M, Hüttelmaier S. |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 101 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? By Jessica L. Bell, Kristin Wächter, Britta Mühleck, Nikolaos Pazaitis, Marcel Köhn, Marcell Lederer, Stefan Hüttelmaier Published in: Cellular and Molecular Life Sciences: CMLS DOI: 10.1007/s00018-012-1186-z ABSTRACT The insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1, IGF2BP2, IGF2BP3) belong to a conserved family of RNA-binding, oncofetal proteins. Several studies have shown that these proteins act in various important aspects of cell function, such as cell polarization, migration, morphology, metabolism, proliferation and differentiation. In this review, we discuss the IGF2BP family’s role in cancer biology and how this correlates with their proposed functions during embryogenesis. IGF2BPs are mainly expressed in the embryo, in contrast with comparatively lower or negotiable levels in adult tissues. IGF2BP1 and IGF2BP3 have been found to be re-expressed in several aggressive cancer types. Control of IGF2BPs’ expression is not well understood; however, let-7 microRNAs, β-catenin (CTNNB1) and MYC have been proposed to be involved in their regulation. In contrast to many other RNA-binding proteins, IGF2BPs are almost exclusively observed in the cytoplasm where they associate with target mRNAs in cytoplasmic ribonucleoprotein complexes (mRNPs). During development, IGF2BPs are required for proper nerve cell migration and morphological development, presumably involving the control of cytoskeletal remodeling and dynamics, respectively. Likewise, IGF2BPs modulate cell polarization, adhesion and migration in tumor-derived cells. Moreover, they are highly associated with cancer metastasis and the expression of oncogenic factors (KRAS, MYC and MDR1). However, a pro-metastatic role of IGF2BPs remains controversial due to the lack of ‘classical’ in vivo studies. Nonetheless, IGF2BPs could provide valuable targets in cancer treatment with many of their in vivo roles to be fully elucidated. Electronic supplementary material The online version of this article (doi:10.1007/s00018-012-1186-z) contains supplementary material, which is available to authorized users. INTRODUCTION The insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (gene symbols: IGF2BP1, IGF2BP2, IGF2BP3) belong to a highly conserved protein family, which as their name suggests can bind RNA and influence their transcript target’s fate. Nomenclature of the IGF2BP protein family remains confusing due to the many synonyms used throughout recent literature including: IMP, CRD-BP, VICKZ, ZBP, Vg1RBP/Vera or KOC. These synonyms may reflect the evolution of the various fields of IGF2BP family research which suggest that these RNA-binding proteins (RBPs) modulate important aspects of cell function during development and in cancer. In this review, we discuss the rapidly growing research into the IGF2BP family’s involvement in cancer biology and the mechanisms by which high expression of these RBPs could cause an aggressive malignancy phenotype. We also discuss the molecular mechanisms by which these proteins facilitate their various functions, their role in cell migration and the need for better research tools to facilitate the next generation of IGF2BP research. In mammals, the canonical structures of the three IGF2BP proteins are strikingly similar in order and spacing of domains (Fig. 1a), leading to proteins of calculated molecular weights ranging from 58 to 66 kDa. There is over 56 % amino acid sequence identity between the three proteins with greater degree of similarity seen within the protein domains. These similarities suggest that the proteins share biochemical functions. Notably, IGF2BP1 and 3 show a higher identity of 73 % with each other (Fig. 1b). All three proteins carry two RNA-recognition motifs (RRMs) in their N-terminal part and four hnRNP-K homology (KH) domains in the C-terminal region. Notably, only one IGF2BP ortholog has been reported in Xenopus, termed Vg1RBP/Vera. This shows the highest homology to mammalian IGF2BP3. In Drosophila, a protein lacking the N-terminal RRM domain but comprising four KH-domains has been suggested as Drosophila IGF2BP (dIMP).Fig. 1The IGF2BP protein family. a Domain structure of humanIGF2BPs and additionally, the IMP ortholog (dIMP, isoform K) of Drosophila melanogaster. RNA-binding domains comprising RNA recognition motifs (RRMs, blue) and hnRNP-K homology domains (KH, red). The following proteins are shown: IGF2BP1 (Acc. no.: NM006546), the longest IGF2BP1 protein isoform; IGF2BP2-a (Acc. no.: NM006548), the longest IGF2BP2 protein isoform; IGF2BP2-a* (no Acc. no. available), truncated IGF2BP2-a resulting from leaky scanning during translation initiation [58]; IGF2BP2-b (Acc. no.: NM001007225.1), spliced IGF2BP-a lacking exon 10; IGF2BP3 (Acc. no.: NM006547), the only reported variant of this paralogue; dIMP (Acc. no.: NM001042803), variant K of the Drosophila melanogaster ortholog of IGF2BPs. b Phylogentic tree indicating amino acid substitutions of distinct IGF2BP paralogues from different species (hu human, mu murine, ch chicken, xo Xenopus, d Drosophila). The accession number for each ortholog is indicated Regardless of organism or cell type, all members of the IGF2BP protein family have been shown to bind RNA, whereas an association with DNA has only been reported once for the Xenopus variant of protein [1]. In vitro studies revealed that RNA-binding is mainly facilitated via the KH-domains [2], although the RRM-domains could potentially contribute to the stabilization of IGF2BP-RNA complexes with target-dependent in vitro half-life greater than 2 h [3]. Recent structural analyses of human IGF2BP1 KH-domains 3 and 4 suggest the formation of an anti-parallel pseudo-dimer conformation in which KH3 and KH4 each contact the targeted RNA [4]. Although final proof of this hypothesis requires protein–RNA co-crystals, these findings suggest that IGF2BPs force associated transcripts into a specific conformation. In light of the surprisingly long half-life of IGF2BP-RNA complexes in vitro, this provides evidence for an essential role of IGF2BPs in promoting the formation of ‘stable’ protein–RNA complexes. The ribonucleoprotein (RNP) granule connection IGF2BPs are predominately cytoplasmic, usually with a granular appearance. A nuclear role of IGF2BPs remains controversial, although there is evidence that IGF2BPs may already associate with their target mRNAs at their site of transcription [5–7]. In agreement, IGF2BPs were observed in the nucleus of spermatogenic cells and were suggested to comprise nuclear export signals [8]. In the cytoplasm, IGF2BPs form distinct ribonucleoprotein (RNP) granules which are enriched in the peri-nuclear region but are also observed in neurites of developing neurons supporting a role of IGF2BPs in promoting mRNA localization [2, 9]. Like most RNA-binding proteins (RBPs), IGF2BPs associate with various other RBPs in an RNA-dependent manner [10, 11]. However, in contrast to other proteins involved in the control of cytoplasmic mRNA fate, IGF2BPs apparently associate predominantly with ‘virgin’ mRNAs. This notion is supported by the observed association with components of the exon junction complex (EJC) as well as CBP80 whereas IGF2BPs do not copurify with eIF4E protein [10, 11]. Hence, IGF2BPs apparently ‘cage’ their target mRNAs in cytoplasmic protein–RNA complexes, termed mRNPs. This prevents the premature decay of specific target transcripts, for instance, CD44, MYC, PTEN or BTRC, presumably by limiting the release of protein-associated transcripts [12–16]. IGF2BP-directed recruitment of targeted mRNAs to cytoplasmic mRNPs is also consistent with their role in controlling mRNA translation and transport. The formation of stable protein–RNA association, as suggested based on in vitro studies [3], provides a bona fide mechanism to prevent promiscuous translation of transported mRNAs. The stable ‘caging’ of transported mRNAs allows for their ‘long-distance’ transport as well as transient storage. Consistently, IGF2BPs have been shown to direct the localization and spatially restrict translation of the β-actin (ACTB) mRNA to exploratory growth cones of developing neuronal cells [6, 9]. Moreover, IGF2BP1 was shown to stabilize its target transcripts during cellular stress when global mRNA translation is severely